Cargando…
Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients
BACKGROUND: The COVID-19 pandemic due to SARS-CoV-2 infection can produce Acute Respiratory Distress Syndrome as a result of a pulmonary cytokine storm. Antihistamines are safe and effective treatments for reducing inflammation and cytokine release. Combinations of Histamine-1 and Histamine-2 recept...
Autores principales: | Hogan II, Reed B., Hogan III, Reed B., Cannon, Tim, Rappai, Maria, Studdard, John, Paul, Doug, Dooley, Thomas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455799/ https://www.ncbi.nlm.nih.gov/pubmed/32871242 http://dx.doi.org/10.1016/j.pupt.2020.101942 |
Ejemplares similares
-
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
por: Malone, Robert W., et al.
Publicado: (2020) -
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
por: Malone, Robert W., et al.
Publicado: (2021) -
Effects of Histamine Receptor Antagonist Cetirizine on Orthodontic Tooth Movement
por: Sperl, Gregor, et al.
Publicado: (2020) -
Cetirizine a histamine H1 receptor antagonist improves viral myocarditis
por: Matsumori, Akira, et al.
Publicado: (2010) -
Effects of the Histamine H2 Receptor Antagonist Famotidine on the Healing of Colonic Anastomosis in Rats
por: İnan, Aydın, et al.
Publicado: (2009)